Intervention not reported
OS not reported · newly diagnosed or relapsed patients with CLL
The review found no eligible studies for this question.
1 finding from 1 review
- Rituximab, ofatumumab and other monoclonal anti‐CD20 antibodies for chronic lymphocytic leukaemia 2012 · Cochrane Headline outcomes onlyno estimate extractedStudies not reportedNo studies found